A non-invasive diagnostic system that checks urine samples for signs of bladder cancer and enables patients to get a fast, accurate diagnosis has won the Medical Technology Association of New Zealand ...
Investing.com - Roth/MKM initiated coverage on Blaize Inc. (NASDAQ:BZAI) with a Buy rating and a price target of $8.50 on Tuesday. The stock, currently trading at $5.05, has shown remarkable momentum ...
On Wednesday, Gentherm (NASDAQ:THRM) Incorporated (NASDAQ:THRM) shares saw its price target increased by Roth/MKM from the previous $65.00 to $68.00, while the firm maintained a Buy rating on the ...
Roth MKM lowered the firm’s price target on SolarEdge (SEDG) to $12 from $20 and keeps a Neutral rating on the shares. The firm cites the company’s “meaningful” Q3 earnings miss while noting that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback